Passage Bio

1 follower


Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).

Industries

Headquarters

Stage

Employees

Links

Org chart

William Chou
President & CEO

William Chou

Collapse
Mark Forman
Chief Medical Officer
James M. Wilson
Chief Scientific Advisor
Edgar B. Cale
General Counsel & Corporate Secretary
Jiwen Zhang
VP, Regulatory Affairs
Samiah Al-Zaidy
VP, Clinical Development
Kathleen Borthwick
VP, Financial Planning & Analysis
Eden Fucci
VP, Manufacturing Operations
Tiffini Voss
VP, Clinical Development
Stuart Henderson
VP, Corporate Development & Investor Relations
Andrea Campanile
VP, Clinical Operations
Sue Browne
VP, Biology
Steve Krausert
Vice President, Supply Chain & Planning
Anne Marie Pierce
Finance Operations Specialist
Nripen Singh
Vice President, Process/analytical/quality Control
Adrienne Meisner
Associate Director, Lab Quality Assurance
Chelsea Difebbo Ortiz
Executive Director, Patient Advocacy
Glen Kerker II
Director, Regulatory Operations